Metraipolis › archive › dc_238d5b2ef515
Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41383624
- DOI
- 10.3389/fimmu.2025.1711415
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:41:20.466Z
- SHA-256 of the archived text
1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc- Stable URL of this page
https://metraipolis.com/documento/dc_238d5b2ef515
How to cite
Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624 — Europe PMC (en), https://europepmc.org/article/MED/41383624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_238d5b2ef515 (Metraipolis archive dc_238d5b2ef515, sha256 1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc)
BibTeX
@misc{dc238d5b2ef515,
title = {Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41383624},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_238d5b2ef515; sha256 1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41383624. Agents can read the archived copy with the MCP tool read_document.